WARNING: This product is for research use only, not for human or veterinary use.
MedKoo CAT#: 562531
Description: YLT192 is an orally active and bioavailable inhibitor of VEGFR2 signaling with potent antiangiogenic activity and antitumor efficacy.
MedKoo Cat#: 562531
Chemical Formula: C21H19N3O4
Exact Mass: 377.1376
Molecular Weight: 377.4
Elemental Analysis: C, 66.83; H, 5.07; N, 11.13; O, 16.96
This product is not in stock, which may be available by custom synthesis.
For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge).
Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.
Synonym: YLT192; YLT-192; YLT 192;
IUPAC/Chemical Name: 4-[4-[(3-Methoxybenzoyl)amino]phenoxy]-N-methyl-2-pyridinecarboxamide
InChi Key: VEAFCVREGPWSCO-UHFFFAOYSA-N
InChi Code: InChI=1S/C21H19N3O4/c1-22-21(26)19-13-18(10-11-23-19)28-16-8-6-15(7-9-16)24-20(25)14-4-3-5-17(12-14)27-2/h3-13H,1-2H3,(H,22,26)(H,24,25)
SMILES Code: O=C(C1=NC=CC(OC2=CC=C(NC(C3=CC=CC(OC)=C3)=O)C=C2)=C1)NC
Appearance: Solid powder
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: Soluble in DMSO
Shelf Life: >2 years if stored properly
Drug Formulation: This drug may be formulated in DMSO
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.9001
The following data is based on the product molecular weight 377.4 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|1 mM||1.15 mL||5.76 mL||11.51 mL|
|5 mM||0.23 mL||1.15 mL||2.3 mL|
|10 mM||0.12 mL||0.58 mL||1.15 mL|
|50 mM||0.02 mL||0.12 mL||0.23 mL|
1: Todescan S, Nizar R. Managing patients with necrotizing ulcerative periodontitis. J Can Dent Assoc. 2013;79:d44. Review. PubMed PMID: 23763731.
2: Titball RW. Clostridium perfringens vaccines. Vaccine. 2009 Nov 5;27 Suppl 4:D44-7. doi: 10.1016/j.vaccine.2009.07.047. Review. PubMed PMID: 19837285.
3: Bieniasz PD, Cullen BR. Chemokine receptors and human immunodeficiency virus infection. Front Biosci. 1998 Jan 1;3:d44-58. Review. PubMed PMID: 9407151.
4: Autran B, Plata F, Guillon JM, Joly P, Mayaud C, Debré P. HIV-specific cytotoxic T lymphocytes directed against alveolar macrophages in HIV-infected patients. Res Virol. 1990 Mar-Apr;141(2):131-6. Review. PubMed PMID: 2189171.